What is enGene's operating income?

enGene's total operating income in 2025 was -$123.17 million, based on the following breakdown: Total Gross Profit: $0.00 Total Operating Expenses: $123.17 million

enGene (ENGN) Financials

$1.90 -0.02 (-1.04%)

Closing price 04:00 PM Eastern

Extended Trading

$1.89 -0.01 (-0.53%)

As of 07:02 PM Eastern

Compare

Annual Income Statements for enGene

This table shows enGene's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2023	2024	2025
Period end date	10/31/2023	10/31/2024	10/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-105	-55	-117
Consolidated Net Income / (Loss)	-100	-55	-117
Net Income / (Loss) Continuing Operations	-100	-55	-117
Total Pre-Tax Income	-100	-55	-117
Total Operating Income	-26	-62	-123
Total Gross Profit	0.00	0.00	0.00
Total Revenue	0.00	0.00	0.00
Total Cost of Revenue	0.00	0.00	0.00
Total Operating Expenses	26	62	123
Selling, General & Admin Expense	9.60	24	29
Research & Development Expense	16	38	94
Total Other Income / (Expense), net	-74	7.25	6.43
Interest Expense	4.95	3.16	2.99
Interest & Investment Income	1.12	10	9.43
Income Tax Expense	0.02	-0.02	0.00
Basic Earnings per Share	$151.22	$1.46	$2.29
Weighted Average Basic Shares Outstanding	692.61K	37.78M	51.12M
Diluted Earnings per Share	$151.22	$1.46	$2.29
Weighted Average Diluted Shares Outstanding	692.61K	37.78M	51.12M
Weighted Average Basic & Diluted Shares Outstanding	-	50.98M	66.98M
Cash Dividends to Common per Share	-	$0.00	$0.00

This table shows enGene's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q1 2026	Q2 2026
Period end date	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	1/31/2026	4/30/2026
Net Income / (Loss) Attributable to Common Shareholders	-5.99	-84	-11	-15	-14	-15	-25	-26	-30	-30
Consolidated Net Income / (Loss)	-4.72	-82	-11	-15	-14	-15	-25	-26	-30	-30
Net Income / (Loss) Continuing Operations	-4.72	-82	-11	-15	-14	-15	-25	-26	-30	-30
Total Pre-Tax Income	-4.72	-82	-11	-15	-14	-15	-25	-26	-30	-30
Total Operating Income	-6.25	-10	-11	-17	-17	-17	-27	-27	-31	-32
Total Gross Profit	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00
Total Revenue	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00
Total Cost of Revenue	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00
Total Operating Expenses	6.25	10	11	17	17	17	27	27	31	32
Selling, General & Admin Expense	2.35	4.77	5.14	7.46	5.21	6.18	6.64	6.92	8.93	9.77
Research & Development Expense	3.90	5.67	5.64	9.86	12	11	20	20	22	22
Total Other Income / (Expense), net	1.53	-72	0.03	2.35	2.58	2.18	1.98	1.75	1.52	1.92
Interest Expense	1.44	1.16	0.93	0.73	0.75	0.76	0.75	0.73	1.22	0.75
Interest & Investment Income	0.39	0.41	1.03	2.98	3.38	3.02	2.73	2.49	2.74	2.66
Income Tax Expense	0.00	0.02	-0.03	0.02	-0.03	0.02	0.02	0.24	0.00	0.00
Basic Earnings per Share	$8.55	$120.08	$0.46	$0.38	$0.32	$0.30	$0.48	($0.51)	$0.44	($0.43)
Weighted Average Basic Shares Outstanding	701.32K	692.61K	23.20M	39.44M	44.17M	37.78M	50.98M	51.02M	67.26M	69.72M
Diluted Earnings per Share	$8.55	$120.08	$0.46	$0.38	$0.32	$0.30	$0.48	($0.51)	$0.44	($0.43)
Weighted Average Diluted Shares Outstanding	701.32K	692.61K	23.20M	39.44M	44.17M	37.78M	50.98M	51.02M	67.26M	69.72M
Weighted Average Basic & Diluted Shares Outstanding	-	0.00	43.58M	44.17M	44.22M	50.98M	50.98M	51.11M	66.99M	66.99M

This table details how cash moves in and out of enGene's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2023	2024	2025
Period end date	10/31/2023	10/31/2024	10/31/2025
Net Change in Cash & Equivalents	61	91	-123
Net Cash From Operating Activities	-25	-48	-99
Net Cash From Continuing Operating Activities	-25	-48	-99
Net Income / (Loss) Continuing Operations	-100	-55	-117
Consolidated Net Income / (Loss)	-100	-55	-117
Depreciation Expense	0.18	0.32	0.51
Amortization Expense	0.00	-0.23	-3.07
Non-Cash Adjustments To Reconcile Net Income	75	8.69	10
Changes in Operating Assets and Liabilities, net	0.49	-1.92	10
Net Cash From Investing Activities	-0.32	-126	-25
Net Cash From Continuing Investing Activities	-0.32	-126	-25
Purchase of Property, Plant & Equipment	-0.32	-0.93	-1.49
Purchase of Investments	0.00	-125	-161
Sale and/or Maturity of Investments	-	0.00	137
Net Cash From Financing Activities	86	266	1.52
Net Cash From Continuing Financing Activities	86	266	1.52
Repayment of Debt	-4.73	-22	-0.70
Issuance of Debt	38	23	0.00
Issuance of Common Equity	57	260	0.00
Other Financing Activities, net	-4.01	5.48	2.22
Effect of Exchange Rate Changes	0.00	0.00	0.00
Cash Interest Paid	1.40	1.93	2.29

This table details how cash moves in and out of enGene's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q1 2026	Q2 2026
Period end date	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	1/31/2026	4/30/2026
Net Change in Cash & Equivalents	20	44	4.13	179	-7.13	-85	-111	-4.80	-14	-6.79
Net Cash From Operating Activities	-7.30	-6.78	-7.37	-14	-7.18	-20	-26	-23	-29	-30
Net Cash From Continuing Operating Activities	-7.30	-6.78	-7.37	-14	-7.18	-20	-26	-23	-29	-30
Net Income / (Loss) Continuing Operations	-4.72	-82	-11	-15	-14	-15	-25	-26	-30	-30
Consolidated Net Income / (Loss)	-4.72	-82	-11	-15	-14	-15	-25	-26	-30	-30
Depreciation Expense	0.04	0.05	0.08	0.08	0.08	0.08	0.10	0.11	0.19	0.18
Amortization Expense	-	-	0.00	-	-	-	-0.78	-1.20	-0.59	-0.49
Non-Cash Adjustments To Reconcile Net Income	-1.10	73	2.13	2.02	2.68	1.82	2.10	2.91	3.52	5.02
Changes in Operating Assets and Liabilities, net	-1.52	2.42	1.13	-1.28	4.21	-5.94	-2.50	1.25	-2.27	-4.97
Net Cash From Investing Activities	-0.16	-0.14	-0.51	-0.18	-0.00	-125	-85	18	-126	24
Net Cash From Continuing Investing Activities	-0.16	-0.14	-0.51	-0.18	-0.00	-125	-85	18	-126	24
Purchase of Property, Plant & Equipment	-0.16	-0.14	-0.51	-0.18	-0.00	-0.24	-0.30	-0.05	-0.15	-0.10
Purchase of Investments	-	-	0.00	-	-	-	-95	-14	-169	-50
Sale and/or Maturity of Investments	-	-	0.00	-	-	-	10	32	43	74
Net Cash From Financing Activities	28	51	12	194	0.05	60	0.00	0.20	142	0.07
Net Cash From Continuing Financing Activities	28	51	12	194	0.05	60	0.00	0.20	142	0.07
Repayment of Debt	-0.38	-4.35	-9.89	-13	-	-12	0.00	-	-24	0.07
Issuance of Common Equity	-	57	0.00	200	-	60	0.00	-	149	-126
Other Financing Activities, net	-2.06	-1.70	-0.61	6.03	0.05	12	0.00	0.20	0.28	126
Cash Interest Paid	0.27	0.46	0.28	0.58	0.53	0.53	0.53	0.51	0.54	0.46

This table presents enGene's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2023	2024	2025
Period end date	10/31/2023	10/31/2024	10/31/2025
Total Assets	87	311	221
Total Current Assets	85	247	201
Cash & Equivalents	82	173	50
Restricted Cash	0.08	0.07	0.08
Short-Term Investments	0.00	65	144
Prepaid Expenses	1.50	8.63	6.65
Current Deferred & Refundable Income Taxes	2.34	0.33	0.93
Plant, Property, & Equipment, net	0.59	1.17	2.48
Total Noncurrent Assets	0.93	63	18
Long-Term Investments	0.00	60	8.52
Other Noncurrent Operating Assets	0.93	3.12	9.08
Total Liabilities & Shareholders' Equity	87	311	221
Total Liabilities	14	39	54
Total Current Liabilities	5.26	15	32
Short-Term Debt	0.56	0.70	8.00
Accounts Payable	1.16	1.41	6.69
Accrued Expenses	3.54	12	15
Other Current Liabilities	0.00	0.42	2.01
Total Noncurrent Liabilities	9.22	24	22
Long-Term Debt	9.22	22	15
Other Noncurrent Operating Liabilities	0.00	1.43	6.46
Total Equity & Noncontrolling Interests	72	273	168
Total Preferred & Common Equity	72	273	168
Total Common Equity	72	273	168
Common Stock	273	529	541
Retained Earnings	-200	-255	-372
Accumulated Other Comprehensive Income / (Loss)	-1.02	-1.42	-0.89

This table presents enGene's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q1 2026	Q2 2026
Period end date	1/31/2024	4/30/2024	7/31/2024	1/31/2025	4/30/2025	1/31/2026	4/30/2026
Total Assets	93	274	267	286	267	337	308
Total Current Assets	90	270	263	222	228	289	270
Cash & Equivalents	86	265	258	62	58	37	30
Restricted Cash	0.08	0.08	0.08	0.08	0.07	0.07	0.08
Short-Term Investments	-	-	-	151	160	239	229
Prepaid Expenses	2.72	3.51	4.70	8.00	9.98	12	11
Current Deferred & Refundable Income Taxes	1.13	1.21	0.24	0.43	0.53	1.20	0.82
Plant, Property, & Equipment, net	0.99	1.11	1.01	1.37	1.55	2.44	2.34
Total Noncurrent Assets	2.85	2.81	3.17	62	37	45	35
Long-Term Investments	-	-	-	59	34	37	27
Other Noncurrent Operating Assets	2.85	2.81	3.17	3.27	3.02	8.86	8.48
Total Liabilities & Shareholders' Equity	93	274	267	286	267	337	308
Total Liabilities	31	31	37	36	39	56	52
Total Current Liabilities	6.91	6.30	13	13	18	25	21
Short-Term Debt	0.00	0.00	1.34	1.69	3.57	0.19	0.19
Accounts Payable	1.28	0.21	2.86	2.61	1.57	2.44	1.79
Accrued Expenses	5.24	5.67	8.83	8.24	12	20	17
Other Current Liabilities	0.39	0.42	0.42	0.42	0.43	2.32	2.29
Total Noncurrent Liabilities	24	24	23	23	21	31	31
Long-Term Debt	23	23	22	22	20	25	25
Other Noncurrent Operating Liabilities	1.60	1.53	1.48	1.33	1.34	6.22	5.96
Total Equity & Noncontrolling Interests	62	243	230	250	227	282	255
Total Preferred & Common Equity	62	243	230	250	227	282	255
Total Common Equity	62	243	230	250	227	282	255
Common Stock	274	469	471	531	533	684	688
Retained Earnings	-210	-225	-239	-279	-305	-402	-432
Accumulated Other Comprehensive Income / (Loss)	-1.02	-1.02	-1.02	-1.28	-0.97	-0.84	-1.14

This table displays calculated financial ratios and metrics derived from enGene's official financial filings.

Metric	2023	2024	2025
Period end date	10/31/2023	10/31/2024	10/31/2025
DEI Shares Outstanding	0.00	-	51,105,201.00
DEI Adjusted Shares Outstanding	0.00	-	51,105,201.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	-	-2.28
Growth Metrics	-	-	-
Revenue Growth	0.00%	0.00%	0.00%
EBITDA Growth	0.00%	35.01%	-102.11%
EBIT Growth	0.00%	35.03%	-97.71%
NOPAT Growth	0.00%	-139.05%	-97.71%
Net Income Growth	0.00%	44.81%	-112.73%
EPS Growth	0.00%	-99.03%	56.85%
Operating Cash Flow Growth	0.00%	-95.13%	-105.54%
Free Cash Flow Firm Growth	0.00%	0.00%	-88.90%
Invested Capital Growth	0.00%	-421.89%	-426.36%
Revenue Q/Q Growth	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	51.98%	0.00%
Profitability Metrics	-	-	-
Gross Margin	0.00%	0.00%	0.00%
EBITDA Margin	0.00%	0.00%	0.00%
Operating Margin	0.00%	0.00%	0.00%
EBIT Margin	0.00%	0.00%	0.00%
Profit (Net Income) Margin	0.00%	0.00%	0.00%
Tax Burden Percent	100.02%	99.97%	100.00%
Interest Burden Percent	103.99%	88.38%	95.24%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%
Return on Equity (ROE)	-137.84%	-31.96%	-53.28%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%
Return on Assets (ROA)	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	-137.84%	-31.96%	-53.28%
Return on Equity Simple (ROE_SIMPLE)	-137.84%	-20.23%	0.00%
Net Operating Profit after Tax (NOPAT)	-18	-44	-86
NOPAT Margin	0.00%	0.00%	0.00%
Net Nonoperating Expense Percent (NNEP)	-113.72%	-6.66%	-13.70%
Return On Investment Capital (ROIC_SIMPLE)	-22.17%	-14.74%	-45.13%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	0.00%	0.00%
Earnings before Interest and Taxes (EBIT)	-96	-62	-123
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-96	-62	-126
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.00	1.44	2.20
Price to Tangible Book Value (P/TBV)	0.00	1.44	2.20
Price to Revenue (P/Rev)	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.13	0.09	0.14
Long-Term Debt to Equity	0.13	0.08	0.09
Financial Leverage	-0.99	-1.00	-1.03
Leverage Ratio	1.20	1.15	1.21
Compound Leverage Factor	1.25	1.02	1.15
Debt to Total Capital	11.89%	7.83%	12.21%
Short-Term Debt to Total Capital	0.68%	0.24%	4.19%
Long-Term Debt to Total Capital	11.20%	7.60%	8.02%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	88.11%	92.17%	87.79%
Debt to EBITDA	-0.10	-0.37	-0.19
Net Debt to EBITDA	0.75	4.41	1.42
Long-Term Debt to EBITDA	-0.10	-0.36	-0.12
Debt to NOPAT	-0.54	-0.53	-0.27
Net Debt to NOPAT	3.94	6.30	2.08
Long-Term Debt to NOPAT	-0.51	-0.52	-0.18
Altman Z-Score	0.00	5.18	0.84
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	16.25	16.87	6.30
Quick Ratio	15.51	16.26	6.06
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-41	-77
Operating Cash Flow to CapEx	-7,780.82%	-5,219.57%	-6,682.76%
Free Cash Flow to Firm to Interest Expense	0.00	-12.89	-25.74
Operating Cash Flow to Interest Expense	-5.00	-15.26	-33.15
Operating Cash Flow Less CapEx to Interest Expense	-5.06	-15.55	-33.64
Efficiency Ratios	-	-	-
Asset Turnover	0.00	0.00	0.00
Accounts Receivable Turnover	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-
Invested Capital	0.67	-2.15	-11
Invested Capital Turnover	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	0.00	-2.81	-9.15
Enterprise Value (EV)	0.00	117	189
Market Capitalization	0.00	391	368
Book Value per Share	$104.66	$6.17	$3.28
Tangible Book Value per Share	$104.66	$6.17	$3.28
Total Capital	82	296	191
Total Debt	9.78	23	23
Total Long-Term Debt	9.22	22	15
Net Debt	-72	-275	-179
Capital Expenditures (CapEx)	0.32	0.93	1.49
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.85	-5.00	-16
Debt-free Net Working Capital (DFNWC)	81	233	177
Net Working Capital (NWC)	80	233	169
Net Nonoperating Expense (NNE)	82	12	31
Net Nonoperating Obligations (NNO)	-72	-275	-179
Total Depreciation and Amortization (D&A)	0.18	0.09	-2.56
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%
Net Working Capital to Revenue	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.00	$1.46	$2.29
Adjusted Weighted Average Basic Shares Outstanding	0.00	37.78M	51.12M
Adjusted Diluted Earnings per Share	$0.00	$1.46	$2.29
Adjusted Weighted Average Diluted Shares Outstanding	0.00	37.78M	51.12M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	50.98M	66.98M
Normalized Net Operating Profit after Tax (NOPAT)	-18	-44	-86
Normalized NOPAT Margin	0.00%	0.00%	0.00%
Pre Tax Income Margin	0.00%	0.00%	0.00%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-19.40	-19.73	-41.14
NOPAT to Interest Expense	-3.68	-13.78	-28.80
EBIT Less CapEx to Interest Expense	-19.46	-20.02	-41.63
NOPAT Less CapEx to Interest Expense	-3.75	-14.07	-29.29
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from enGene's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q1 2026	Q2 2026
Period end date	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	1/31/2026	4/30/2026
DEI Shares Outstanding	0.00	0.00	0.00	43,581,331.00	44,166,159.00	-	-	50,977,560.00	66,984,661.00	66,989,466.00
DEI Adjusted Shares Outstanding	0.00	0.00	0.00	43,581,331.00	44,166,159.00	-	-	50,977,560.00	66,984,661.00	66,989,466.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	0.00	0.00	-0.34	-0.32	-	-	-0.51	-0.44	-0.45
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Growth	0.00%	0.00%	-69.03%	-306.47%	-360.84%	78.62%	-153.38%	-64.59%	-15.73%	-14.42%
EBIT Growth	0.00%	0.00%	-69.06%	-304.77%	-357.68%	78.53%	-145.23%	-57.52%	-17.18%	-17.86%
NOPAT Growth	0.00%	0.00%	-132.53%	-265.42%	-168.23%	-67.16%	-147.03%	-56.70%	-17.18%	-17.86%
Net Income Growth	0.00%	0.00%	-44.39%	-183.68%	-199.75%	81.46%	-129.82%	-72.28%	-20.86%	-17.09%
EPS Growth	0.00%	0.00%	-96.54%	-95.91%	-96.26%	-99.75%	4.35%	-234.21%	-8.33%	15.69%
Operating Cash Flow Growth	0.00%	0.00%	-18.43%	-218.68%	1.63%	-188.78%	-248.66%	-62.03%	-12.48%	-32.91%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-195.82%	-35.26%	23.62%	-3.44%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%	-421.89%	157.83%	-184.96%	-1,411.94%	-622.50%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	13.94%	-2,150.73%	86.83%	-59.35%	2.43%	-4.43%	-56.06%	-3.37%	0.00%	-2.20%
EBIT Q/Q Growth	13.68%	-2,125.71%	86.74%	-58.89%	2.40%	-4.42%	-51.45%	-1.92%	0.00%	-2.51%
NOPAT Q/Q Growth	-31.90%	-67.13%	-3.17%	-60.68%	3.18%	-4.15%	-52.47%	-1.92%	0.00%	-2.51%
Net Income Q/Q Growth	10.64%	-1,647.82%	87.02%	-39.89%	5.58%	-8.14%	-60.90%	-4.87%	0.00%	-1.60%
EPS Q/Q Growth	-8.06%	1,304.44%	-99.62%	-17.39%	-15.79%	-6.25%	60.00%	-206.25%	0.00%	-197.73%
Operating Cash Flow Q/Q Growth	-64.27%	7.18%	-8.77%	-92.16%	49.29%	-172.50%	-31.32%	10.70%	0.00%	-5.52%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-92.09%	43.84%	-29.53%	-111.70%	12.17%	0.00%	-18.95%
Invested Capital Q/Q Growth	0.00%	0.00%	-221.59%	200.00%	-651.29%	51.98%	121.84%	-246.91%	0.00%	19.10%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profit (Net Income) Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Tax Burden Percent	100.00%	100.02%	99.72%	100.14%	99.80%	100.12%	100.07%	100.94%	100.00%	100.00%
Interest Burden Percent	128.54%	100.92%	99.11%	86.90%	84.36%	87.08%	92.56%	94.29%	95.40%	94.55%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	0.00%	-137.84%	-165.44%	-46.47%	0.00%	-31.96%	-44.21%	-33.97%	-46.07%	-52.58%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-11,935.16%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (ROA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	0.00%	-137.84%	-165.44%	-46.47%	0.00%	-31.96%	-44.21%	-33.97%	-46.07%	-52.58%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	-165.44%	-46.47%	0.00%	0.00%	-27.62%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-4.37	-7.31	-7.54	-12	-12	-12	-19	-19	-22	-22
NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Nonoperating Expense Percent (NNEP)	0.00%	-104.69%	-10.03%	-2.37%	-2.06%	-1.78%	-3.83%	-2.90%	-2.95%	-3.22%
Return On Investment Capital (ROIC_SIMPLE)	-	-8.89%	-8.88%	-4.56%	-	-4.13%	-6.82%	-7.57%	-7.12%	-7.98%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings before Interest and Taxes (EBIT)	-3.67	-82	-11	-17	-17	-18	-27	-27	-31	-32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-3.63	-82	-11	-17	-17	-17	-27	-28	-32	-32
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	2.85	1.82	1.44	1.37	0.93	2.27	1.91
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	2.85	1.82	1.44	1.37	0.93	2.27	1.91
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	555.84	0.00	0.00	196.30	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.13	0.36	0.09	0.10	0.09	0.09	0.10	0.09	0.10
Long-Term Debt to Equity	0.00	0.13	0.36	0.09	0.09	0.08	0.09	0.09	0.09	0.10
Financial Leverage	0.00	-0.99	-1.01	-1.00	-1.02	-1.00	-1.00	-1.00	-1.01	-1.01
Leverage Ratio	0.00	1.20	1.50	1.13	1.16	1.15	1.21	1.15	1.17	1.19
Compound Leverage Factor	0.00	1.21	1.48	0.98	0.98	1.00	1.12	1.08	1.12	1.13
Debt to Total Capital	0.00%	11.89%	26.53%	8.55%	9.06%	7.83%	8.56%	9.40%	8.13%	8.96%
Short-Term Debt to Total Capital	0.00%	0.68%	0.00%	0.00%	0.53%	0.24%	0.62%	1.42%	0.06%	0.07%
Long-Term Debt to Total Capital	0.00%	11.20%	26.53%	8.55%	8.53%	7.60%	7.94%	7.98%	8.07%	8.89%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	88.11%	73.47%	91.45%	90.94%	92.17%	91.44%	90.60%	91.87%	91.04%
Debt to EBITDA	0.00	-0.10	-0.22	-0.20	0.00	-0.37	-0.30	-0.26	-0.19	-0.19
Net Debt to EBITDA	0.00	0.75	0.63	2.14	0.00	4.41	3.17	2.54	2.21	1.94
Long-Term Debt to EBITDA	0.00	-0.10	-0.22	-0.20	0.00	-0.36	-0.28	-0.22	-0.19	-0.19
Debt to NOPAT	0.00	-0.54	-1.00	-0.73	0.00	-0.53	-0.43	-0.38	-0.28	-0.27
Net Debt to NOPAT	0.00	3.94	2.80	7.73	0.00	6.30	4.56	3.70	3.22	2.80
Long-Term Debt to NOPAT	0.00	-0.51	-1.00	-0.73	0.00	-0.52	-0.40	-0.33	-0.28	-0.27
Altman Z-Score	0.00	0.00	0.00	13.40	6.54	5.65	4.90	2.22	5.86	4.24
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	16.25	12.97	42.80	19.52	16.87	17.16	12.66	11.75	12.57
Quick Ratio	0.00	15.51	12.40	42.04	19.15	16.26	16.50	12.08	11.21	12.03
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	-6.73	-13	-7.26	-9.40	-20	-17	-15	-18
Operating Cash Flow to CapEx	-4,649.68%	-4,910.14%	-1,456.52%	-7,911.73%	-359,050.00%	-8,221.85%	-8,593.98%	-50,993.33%	-18,890.85%	-31,120.41%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-7.24	-17.76	-9.67	-12.44	-26.47	-23.82	-12.47	-24.28
Operating Cash Flow to Interest Expense	-5.06	-5.85	-7.93	-19.45	-9.56	-25.88	-34.17	-31.26	-23.69	-40.94
Operating Cash Flow Less CapEx to Interest Expense	-5.17	-5.97	-8.48	-19.70	-9.56	-26.20	-34.57	-31.32	-23.82	-41.07
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	0.67	-0.81	0.81	-4.47	-2.15	0.47	-0.69	-6.15	-4.98
Invested Capital Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	0.00	0.00	-0.81	0.81	-4.47	-2.81	1.28	-1.50	-6.62	-4.29
Enterprise Value (EV)	0.00	0.00	0.00	451	185	117	92	-17	351	227
Market Capitalization	0.00	0.00	0.00	693	420	391	342	211	638	487
Book Value per Share	$0.00	$104.66	$2.69	$5.58	$5.22	$6.17	$4.90	$4.46	$4.20	$3.81
Tangible Book Value per Share	$0.00	$104.66	$2.69	$5.58	$5.22	$6.17	$4.90	$4.46	$4.20	$3.81
Total Capital	0.00	82	85	266	253	296	273	251	306	280
Total Debt	0.00	9.78	23	23	23	23	23	24	25	25
Total Long-Term Debt	0.00	9.22	23	23	22	22	22	20	25	25
Net Debt	0.00	-72	-63	-242	-235	-275	-249	-228	-288	-260
Capital Expenditures (CapEx)	0.16	0.14	0.51	0.18	0.00	0.24	0.30	0.05	0.15	0.10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-0.85	-3.05	-1.58	-7.18	-5.00	-2.83	-3.92	-11	-9.83
Debt-free Net Working Capital (DFNWC)	0.00	81	83	263	251	233	211	214	265	249
Net Working Capital (NWC)	0.00	80	83	263	249	233	209	210	265	249
Net Nonoperating Expense (NNE)	0.35	75	3.17	2.87	2.42	3.08	5.99	6.83	7.92	7.85
Net Nonoperating Obligations (NNO)	0.00	-72	-63	-242	-235	-275	-249	-228	-288	-260
Total Depreciation and Amortization (D&A)	0.04	0.05	0.08	0.08	0.08	0.08	-0.68	-1.09	-0.40	-0.31
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$120.08	$0.46	$0.38	$0.32	$0.30	$0.48	$0.51	$0.44	($0.43)
Adjusted Weighted Average Basic Shares Outstanding	0.00	692.61K	23.20M	39.44M	44.17M	37.78M	50.98M	51.02M	67.26M	69.72M
Adjusted Diluted Earnings per Share	$0.00	$120.08	$0.46	$0.38	$0.32	$0.30	$0.48	$0.51	$0.44	($0.43)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	692.61K	23.20M	39.44M	44.17M	37.78M	50.98M	51.02M	67.26M	69.72M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	43.58M	44.17M	44.22M	50.98M	50.98M	51.11M	66.99M	66.99M
Normalized Net Operating Profit after Tax (NOPAT)	-4.37	-7.31	-7.54	-12	-12	-12	-19	-19	-22	-22
Normalized NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Pre Tax Income Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-2.55	-70.52	-11.67	-23.65	-22.38	-23.21	-35.34	-36.95	-25.56	-42.91
NOPAT to Interest Expense	-3.03	-6.31	-8.12	-16.64	-15.62	-16.16	-24.77	-25.87	-17.89	-30.04
EBIT Less CapEx to Interest Expense	-2.66	-70.64	-12.21	-23.90	-22.38	-23.53	-35.74	-37.02	-25.69	-43.04
NOPAT Less CapEx to Interest Expense	-3.14	-6.43	-8.66	-16.89	-15.62	-16.48	-25.17	-25.93	-18.02	-30.17
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

enGene Financials - Frequently Asked Questions

According to the most recent income statement we have on file, enGene's fiscal year ends in October. Their fiscal year 2025 ended on October 31, 2025.

enGene's net income appears to be on an upward trend, with a most recent value of -$117.30 million in 2025, rising from -$99.92 million in 2023. The previous period was -$55.14 million in 2024. Check out enGene's forecast to explore projected trends and price targets.

enGene's total operating income in 2025 was -$123.17 million, based on the following breakdown:

Total Gross Profit: $0.00
Total Operating Expenses: $123.17 million

Over the last 2 years, enGene's total revenue changed from $0.00 in 2023 to $0.00 in 2025, a change of 0.0%.

enGene's total liabilities were at $53.76 million at the end of 2025, a 39.4% increase from 2024, and a 271.4% increase since 2023.

In the past 2 years, enGene's cash and equivalents has ranged from $50.15 million in 2025 to $173.00 million in 2024, and is currently $50.15 million as of their latest financial filing in 2025.

Over the last 2 years, enGene's book value per share changed from 104.66 in 2023 to 3.28 in 2025, a change of -96.9%.

Related Companies

Financial statements for NASDAQ:ENGN last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

enGene (ENGN) Financials

Financials Breakdown Chart

enGene Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

enGene (ENGN) Financials

Annual Income Statements for enGene

Quarterly Income Statements for enGene

Annual Cash Flow Statements for enGene

Quarterly Cash Flow Statements for enGene

Annual Balance Sheets for enGene

Quarterly Balance Sheets for enGene

Annual Metrics And Ratios for enGene

Quarterly Metrics And Ratios for enGene

Financials Breakdown Chart

enGene Financials - Frequently Asked Questions

When does enGene's financial year end?

How has enGene's net income changed over the last 2 years?

What is enGene's operating income?

How has enGene's revenue changed over the last 2 years?

How much debt does enGene have?

How much cash does enGene have?

How has enGene's book value per share changed over the last 2 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools